The Microbiome Connect: Gut Therapeutics Summit returns as a face-to-face event on 7-8 December. It brings together microbiome academic researchers, pharmaceutical & biotechnology organisations, regulatory bodies, and service providers. The event will have two streams. The prime one is dedicated to R&D, enabling pre & post-clinical conversations and critical examination into new targeted therapeutic research into microbiomes such as gut-brain axis relationship, immuno-oncology, and gastrointestinal indications. The manufacturing stream will facilitate the standardisation of LBP’s & probiotics, finding the right CDMO partner and solutions to microbiome-based therapies production challenges to up-skill capability.

30+ industry-leading speakers, including:

• Nestle’s Gut-Brain Axis specialist Marcus Bohme will discuss detecting interrelationship in the microbiome and brain ageing
• 4D Pharma’s CMC & Development SVP Christophe Carite sharing the latest LBP and probiotics manufacturing and standardisation regulations
• EverImmune’s Head of Preclinical research will talk about reverse resistance to anticancer therapeutics by modulating the gut microbiota in a personalised approach
• APC Microbiome’s Investigator, Niall Hyland, will explore the latest research into how drugs and the microbiome interact

The full event schedule is available here.

Register here or click on the Request Information below below.